Vimarsana
Biggest News Aggregation in the World

Page 2 - Multiple Sclerosis Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Multiple Sclerosis Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Multiple Sclerosis Research Today - Breaking & Trending Today

Oral medication is leading choice for multiple sclerosis treatment: Study - Vimarsana News

Oral medication is leading choice for multiple sclerosis treatment: Study

The study states that oral medication is the preferred choice for treating multiple sclerosis due to convenience, promotion, and approval by health insurers. | Health

Tiziana Life Sciences Ltd.: Tiziana Life Sciences to Host KOL Webinar on Foralumab in Non-Active Secondary Progressive Multiple Sclerosis (SPMS) - Vimarsana News

Tiziana Life Sciences Ltd.: Tiziana Life Sciences to Host KOL Webinar on Foralumab in Non-Active Secondary Progressive Multiple Sclerosis (SPMS)

Webinar to take place on Monday, June 5, 2023 at 12:30 PM ETNEW YORK, May 25, 2023) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies via novel routes

Dr. Rhonda Voskuhl receives grant to discover neuroprotective treatments for MS - Vimarsana News

Dr. Rhonda Voskuhl receives grant to discover neuroprotective treatments for MS

The $7.3 million award from the National Institute of Neurological Disorders and Stroke will support the professor’s research.

Source: ucla.edu
Nimbus Therapeutics Appoints Nathalie Franchimont, M.D., Ph.D., as Chief Medical Officer - Vimarsana News

Nimbus Therapeutics Appoints Nathalie Franchimont, M.D., Ph.D., as Chief Medical Officer

Nimbus Therapeutics Appoints Nathalie Franchimont, M.D., Ph.D., as Chief Medical Officer - read this article along with other careers information, tips and advice on BioSpace

Helius Medical Technologies, Inc. Announces Participation of Dr. Deborah Backus and Shepherd Center in its Therapeutic Experience Program - Vimarsana News

Helius Medical Technologies, Inc. Announces Participation of Dr. Deborah Backus and Shepherd Center in its Therapeutic Experience Program

-- Second Center of Excellence added in multi-center, company-sponsored, open label observational interventional trial to evaluate the impact of subjects’ adherence to PoNS® therapy for gait... | May 17, 2022